title: Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy.
abstract: Cancer is the leading cause of death worldwide. Current cancer treatments in the clinic mainly include chemotherapy, radiotherapy and surgery, with chemotherapy being the most common. Areas covered: Cancer treatments based on the single 'magic-bullet' concept are often associated with limited therapeutic efficacy, unwanted adverse effects, and drug resistance. The combination of multiple drugs is a promising strategy for effective cancer treatment due to the synergistic or additive effects. Small interfering RNA (siRNA) has the ability to knock down the expression of carcinogenic genes or drug efflux transporter genes, paving the way for cancer treatment. Treatment with both a chemotherapeutic agent and siRNA based on nanoparticle (NP)-mediated co-delivery is a promising approach for combination cancer therapy. Expert opinion: The combination of chemotherapeutic agents and siRNAs for cancer treatment offers the potential to enhance therapeutic efficacy, decrease side effects, and overcome drug resistance. Co-delivery of chemical drug and siRNA in the same NP would be much more effective in cancer therapy than application of chemical agent or siRNA alone. With the development of material science, NPs have come to be the most widely used platform for co-delivery of chemotherapeutic drugs and siRNAs.
authors.affiliation: a Institute for Clean Energy and Advanced Materials , Faculty for Materials and Energy, Southwest University , Chongqing , P. R. China.|b Center for Diagnostics and Therapeutics, Institute for Biomedical Sciences , Georgia State University , Atlanta , GA , USA.
authors.forename: Bo
authors.initials: B
authors.lastname: Xiao
authors.affiliation: a Institute for Clean Energy and Advanced Materials , Faculty for Materials and Energy, Southwest University , Chongqing , P. R. China.
authors.forename: Lijun
authors.initials: L
authors.lastname: Ma
authors.affiliation: b Center for Diagnostics and Therapeutics, Institute for Biomedical Sciences , Georgia State University , Atlanta , GA , USA.|c Veterans Affairs Medical Center , Decatur , GA , USA.
authors.forename: Didier
authors.initials: D
authors.lastname: Merlin
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D006801:Humans; D053758:Nanoparticles; D009369:Neoplasms / Q000628:therapy*; D034741:RNA, Small Interfering / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D034741:RNA, Small Interfering
keywords: Co-delivery; cancer; chemical drug; combination therapy; nanoparticle; siRNA